Pharvaris PHVS
NASDAQ PHVS
$30.94 +0.04 (+0.13%)
As of: Oct 21, 2026 · 1:33 PM EDT

Pharvaris (PHVS) Other Non-Current Liabilities (2023 - 2024)

Updated

Analysis

Pharvaris (PHVS) Other Non-Current Liabilities (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.17 Bn 1,102.76 Bn 19.71 Bn
2 Johnson & Johnson 615.84 Bn 534.36 Bn 17.26 Bn
3 AbbVie 500.69 Bn 473.80 Bn 12.70 Bn
4 Merck 367.34 Bn 321.72 Bn 12.21 Bn
5 Novartis Ag 297.61 Bn 261.60 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.75 Bn 12.86 Bn
7 Amgen 235.51 Bn 190.91 Bn 7.24 Bn
8 Gilead Sciences 190.60 Bn 164.80 Bn 6.22 Bn
9 Pfizer 169.37 Bn 116.02 Bn 10.94 Bn
10 Pharvaris 1.83 Bn 455.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 3.93 Mn
Dec 31, 2023 744,321.49
API Access

Pharvaris Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PHVS&period=max&api_key=YOUR_API_KEY